{
  "indication": "Alzheimer's disease",
  "drug_name": "IL-2",
  "drug_form": "low-dose IL-2",
  "drug_generic_name": "Aldesleukin",
  "indication_aliases": [
    "Alzheimer disease",
    "Alzheimer dementia"
  ],
  "drug_aliases": [
    "Aldesleukin",
    "COYA 301"
  ],
  "research_section_market_opportunity_analysis": {
    "summary": "Targeted gap collection for market opportunity."
  }
}
